Skip to: Content
Skip to: Site Navigation
Skip to: Search
SUNDAY, NOVEMBER 22, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: Johnson and Johnson

Johnson and Johnson stories: 11 news summaries

Johnson & Johnson to
Slash 8,700 Jobs

Company says moves will save up to $900M annually

Nov 3, 09 8:56 AM CST
(AP) - Johnson & Johnson will cut 7% of its workforce—some 8,400 jobs—and make other other restructuring moves in order to save up to $900 million next year. The New Brunswick, NJ, company says it will also simplify its business structure in order to achieve savings that will add... More »

MORE ABOUT:
cost cutting • Johnson and Johnson • restructuring • job cuts

MARKETS

 Dow Up 124 on Revitalized M&A 

Xerox, J&J announce new acquisitions

Sep 28, 09 3:18 PM CDT
(Newser) - High-profile deals breathed fresh life into stocks today, snapping a 3-day losing streak. Xerox will buy outsourcing company Affiliated Computer Services for $6.4 billion, and Johnson and Johnson bought biotech firm Crucell for $442.7 million. Barring sharp losses in the days ahead, this quarter will have seen the... More »

MORE ABOUT:
Dow Jones • Johnson and Johnson • Nasdaq • S&P 500 • Xerox • Affiliated Computer Services • Crucell

Companies, to Their Lobbyist: Wait, We Care About Climate

Chamber of Commerce faces enviro dissent

May 5, 09 9:42 AM CDT
(Newser) - Cracks are appearing in big business’s monolithic opposition to federal moves to prevent climate change. Politico reports that major members of the Chamber of Commerce, including Nike and Johnson & Johnson, are complaining about the Chamber's resistance to measures like the cap-and-trade bill in Congress. A Nike spokeswoman says... More »

MORE ABOUT:
climate change • Johnson and Johnson • Nike • climate change legislation • US Chamber of Commerce

updated

FBI Searches
Home of Tylenol Killings Suspect

Case of seven deaths in 1982 poisoning remains unsolved

Feb 4, 09 3:37 PM CST
(Newser) - FBI agents are searching the former residence of a suspect in the deaths of seven people who took cyanide-laced Tylenol in 1982, the Boston Globe reports. The case has never been solved, and agents say they are reviewing all related evidence. James W. Lewis lived in the Boston-area apartment after... More »

MORE ABOUT:
Chicago • crime • Boston • drug companies • poison • Johnson and Johnson • tainted • Tylenol

Congress
to Probe 'Misleading' Drug Ads

Cholesterol, anemia drugs in spotlight

May 8, 08 3:10 AM CDT
(Newser) - A congressional panel will examine three ad campaigns as part of a move to tighten regulations on drug companies' direct-to-consumer marketing, the Wall Street Journal reports. The committee will focus on ads for cholesterol drugs Vytorin and Lipitor, and anemia drug Procrit, which has been promoted as an anti-fatigue drug... More »

MORE ABOUT:
drugs • advertising • Merck • drug companies • Pfizer • Johnson and Johnson • congressional Democrats • Lipitor • Bart Stupak • Vytorin • Schering-Plough

J&J Hid Birth Control Patch Risks: Suit

Scientist accused of veiling heart attack, stroke dangers

Apr 6, 08 4:40 PM CDT
(Newser) - Johnson & Johnson doctored data to get its birth control patch FDA-approved, according to a class action lawsuit that claims Ortho-Evra caused blood clots, heart attacks, and strokes. A J&J scientist allegedly doctored the data with a "correction factor" for the FDA, lowering estrogen-related risk by 60%: He... More »

MORE ABOUT:
FDA • estrogen • blood clots • birth control • Johnson and Johnson • class action • birth control pill • Ortho-Evra • birth control patch

Overdose Fears Prompt Recall
of Infant Drugs

Danger found in cough and cold medicines
for kids under 2

Oct 11, 07 12:42 PM CDT
(Newser) - Several drugmakers have recalled over-the-counter cough and cold products for infants over concerns about fatal overdoses, Reuters reports. Johnson & Johnson Wyeth and Novartis are among those recalling medicines; CVS said it will remove the products and generic equivalents. One professor took the criticism one step further: “There are... More »

MORE ABOUT:
FDA • drugs • Novartis • recall • Johnson and Johnson • CVS • pharmaceutical • infants • Wyeth

Credit Crunch Hits Bond Market

Tight corporate borrowing could slow economy

Aug 20, 07 3:36 AM CDT
(Newser) - Ripples from the credit crisis have reached the corporate bond market—threatening to slow down the economy by seriously limiting the ability of major corporations to borrow money for new projects,  the Washington Post reports. Credit problems have already begun to bite into the future plans of Hertz, ... More »

MORE ABOUT:
Federal Reserve • General Electric • money • Johnson and Johnson • US economy • Home Depot • Countrywide • bond market • Deere and Co • Wal-Mart

Drug Giant Sues Red Cross Over ... Red Cross

Johnson & Johnson claims trademark infringement

Aug 9, 07 10:52 AM CDT
(Newser) - Pharmaceutical behemoth Johnson & Johnson has filed a lawsuit in federal court against the American Red Cross over its signature logo, the Wall Street Journal reports. The suit claims the humanitarian organization is violating the Johnson & Johnson trademark by licensing the signature red cross symbol to companies for use... More »

MORE ABOUT:
pharmaceutical companies • logo • lawsuit • Johnson and Johnson • Red Cross • American Red Cross • Mark Everson

Dow Breaks 14K, Briefly

Strong earnings, weak inflation boost markets

Jul 17, 07 3:56 PM CDT
(Newser) - The Dow shattered the 14,000 mark for the first time in its history today, floating 22 points above the milestone but dipping just before the bell to close at 13,971.55—still a 20.57-point gain. A projection of relatively docile inflation, combined with continued encouraging earnings reports... More »

MORE ABOUT:
Wall Street • Microsoft • New York Stock Exchange • Intel • Dow Jones • Coca Cola • Johnson and Johnson

Doctors Paid Millions To Use Anemia Drugs

Among the world's top-selling medicines, the FDA now says they
may be unsafe

May 9, 07 8:34 AM CDT
(Newser) - Doctors are paid millions of dollars by drug companies to give their patients anemia medicine which regulators now say may be dangerous. Spurred by competiton between several similar drugs, companies reward doctors with rebates, which allow them to make a significant profit, the New York Times reports. More »

MORE ABOUT:
medicine • FDA • health • pharmaceutical companies • Medicare • Anemia • drug companies • safety • doctor • Johnson and Johnson • Amgen

11 Stories


from our news partners